Pharmacokinetics of loratadine and pseudoephedrine following single and multiple doses of once- versus twice-daily combination tablet formulations in healthy adult males

Clinical Therapeutics

Volumn 19, Issue 5, 1997, Pages 1002-1012

  Kosoglou, Teddy ^a   Radwanski, Elaine ^a   Batra, Vijay K ^a   Lim, Josephine M ^a   Christopher, David ^a   Affrime, Melton B ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Descarboethoxyloratadine; Loratadine; Pharmacokinetics; Pseudoephedrine

Indexed keywords

CLARITIN D; LORATADINE; PSEUDOEPHEDRINE;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERANCE; HEADACHE; HUMAN; INSOMNIA; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL;

EID: 0030702789     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(97)80052-5     Document Type: Article

References (15)

1. Tarnasky PR, Van Arsdel PP Jr. Antihistamine therapy in allergic rhinitis. J Fam Pract. 1990;30:71-80.
2. Dockhorn RJ, Bergner A, Connell JT, et al. Safety and efficacy of loratadine (Sch-29851): A new non-sedating antihistamine in seasonal allergic rhinitis. Ann Allergy. 1987;58:407-411.
3. Irander K, Odkvist LM, Ohlander B. Treatment of hay fever with loratadine: A new nonsedating antihistamine. Allergy. 1990;45:86-91.
4. Gutkowski A, Bedard P, Del Carpio J. Comparison of the efficacy and safety of loratadine, terfenadine and placebo in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 1988;81:902-907.
5. Bruttman G, Pedrali P. Loratadine (SCH 29851) 40 mg OD versus terfenadine 60 mg BID in the treatment of seasonal allergic rhinitis. J Int Med Res. 1987; 15:63-70.
6. Banov CH. Comparative efficacy of once daily loratadine versus terfenadine in the treatment of allergic rhinitis. J Int Med Res. 1989;17:150-156.
7. Del Carpio J, Kabbash L, Turenne Y, et al. Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily) and placebo in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 1989;84:741-746.
8. Oei HD. Double-blind comparison of loratadine (SCH 29851), astemizole and placebo in hay fever with special regard to onset of action. Ann Allergy. 1988; 61:436-439.
9. Kemp JP, Bahna SL, Chervinsky P, et al. A comparison of loratadine, a new nonsedating antihistamine, with clemastine and placebo in patients with fall seasonal allergic rhinitis. Am J Rhinol. 1987;1: 151-154.
10. Skassa-Brociek W, Bousquet J, Montes F, et al. Double-blind, placebo-controlled study of loratadine, mequitazine and placebo in the symptomatic treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 1988;81:725-730.
11. Clissold SP, Sorkin EM, Goa KL. Loratadine: A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs. 1989;37:42-57.
12. Storms WW, Bodman SF, Nathan RA, et al. SCH 434: A new antihistamine/decongestant for seasonal allergic rhinitis. J Allergy Clin Immunol. 1989;83:1083-1090.
13. Prevost M, Turenne Y, Moote DW, et al. Comparative study of SCH 434 and CTM-D in the treatment of seasonal allergic rhinitis. Clin Ther. 1994; 16:50-56.
14. Roman IJ, Danzig MR. Loratadine. A review of recent findings in pharmacology, pharmacokinetics, efficacy, and safety, with a look at its use in combination with pseudoephedrine. Clin Rev Allergy. 1993; 11:89-110.
15. Bronsky E, Boggs P, Findlay S, et al. Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis. J Allergy Clin Immunol. 1995;96:139-147.